Broadfin Capital as of Sept. 30, 2016
Portfolio Holdings for Broadfin Capital
Broadfin Capital holds 67 positions in its portfolio as reported in the September 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Horizon Pharma | 10.7 | $119M | 6.6M | 18.13 | |
| Retrophin | 7.0 | $78M | 3.5M | 22.38 | |
| Novadaq Technologies | 5.4 | $60M | 5.2M | 11.57 | |
| Progenics Pharmaceuticals | 5.1 | $57M | 9.0M | 6.33 | |
| Flamel Technologies | 4.9 | $55M | 4.4M | 12.40 | |
| Heron Therapeutics (HRTX) | 4.9 | $54M | 3.2M | 17.23 | |
| AngioDynamics (ANGO) | 4.5 | $51M | 2.9M | 17.54 | |
| La Jolla Pharmaceuticl Com Par | 3.1 | $34M | 1.4M | 23.79 | |
| SPDR S&P Biotech (XBI) | 3.0 | $33M | 500k | 66.29 | |
| Endo International | 2.6 | $29M | 1.5M | 20.15 | |
| Aratana Therapeutics | 2.6 | $29M | 3.1M | 9.36 | |
| Antares Pharma | 2.2 | $25M | 15M | 1.68 | |
| Lion Biotechnologies | 1.9 | $22M | 2.6M | 8.23 | |
| Recro Pharma | 1.9 | $22M | 2.5M | 8.84 | |
| Aralez Pharmaceuticals | 1.9 | $21M | 4.4M | 4.85 | |
| Ophthotech | 1.7 | $19M | 410k | 46.13 | |
| Medgenics | 1.7 | $19M | 3.4M | 5.57 | |
| Advaxis | 1.5 | $17M | 1.6M | 10.69 | |
| Teligent | 1.5 | $17M | 2.2M | 7.60 | |
| Ignyta | 1.3 | $14M | 2.3M | 6.29 | |
| Dynavax Technologies (DVAX) | 1.3 | $14M | 1.3M | 10.49 | |
| BioDelivery Sciences International | 1.3 | $14M | 5.2M | 2.70 | |
| Teva Pharmaceutical Industries (TEVA) | 1.2 | $14M | 300k | 46.01 | |
| Aegerion Pharmaceuticals | 1.2 | $13M | 4.4M | 2.97 | |
| Acorda Therapeutics | 1.1 | $13M | 605k | 20.88 | |
| Derma Sciences | 1.1 | $12M | 2.6M | 4.67 | |
| Seaspine Holdings | 1.0 | $11M | 1.1M | 10.11 | |
| Qlt | 1.0 | $11M | 5.3M | 2.06 | |
| Corium Intl | 1.0 | $11M | 1.9M | 5.63 | |
| Amarin Corporation (AMRN) | 1.0 | $11M | 3.4M | 3.19 | |
| Endologix | 0.9 | $10M | 800k | 12.80 | |
| Pacira Pharmaceuticals (PCRX) | 0.9 | $10M | 301k | 34.22 | |
| Paratek Pharmaceuticals | 0.9 | $10M | 786k | 13.01 | |
| Intersect Ent | 0.9 | $10M | 639k | 15.84 | |
| Zogenix | 0.9 | $10M | 882k | 11.43 | |
| Redhill Biopharma Ltd cmn | 0.9 | $10M | 717k | 13.89 | |
| Medicines Company | 0.9 | $9.6M | 256k | 37.74 | |
| DepoMed | 0.8 | $9.5M | 380k | 24.97 | |
| DURECT Corporation | 0.8 | $8.9M | 6.4M | 1.39 | |
| Catalyst Pharmaceutical Partners (CPRX) | 0.8 | $8.9M | 8.2M | 1.09 | |
| Egalet Corporation note 5.50% 4/1/20 | 0.8 | $8.8M | 10M | 0.88 | |
| Strongbridge Bioph shs usd | 0.8 | $8.6M | 1.7M | 5.22 | |
| Egalet | 0.8 | $8.6M | 1.1M | 7.61 | |
| Adma Biologics (ADMA) | 0.7 | $8.1M | 1.1M | 7.24 | |
| Aviragen Therapeutics | 0.6 | $6.7M | 3.5M | 1.92 | |
| Mirati Therapeutics | 0.6 | $6.6M | 1.0M | 6.61 | |
| Idera Pharmaceuticals | 0.6 | $6.2M | 2.4M | 2.56 | |
| Raptor Pharmaceutical | 0.5 | $6.0M | 665k | 8.97 | |
| Scynexis | 0.5 | $5.7M | 1.5M | 3.87 | |
| Cardiovascular Systems | 0.5 | $5.5M | 231k | 23.74 | |
| Nevro (NVRO) | 0.5 | $5.3M | 51k | 104.38 | |
| Alcobra | 0.5 | $5.1M | 2.0M | 2.47 | |
| Tenax Therapeutics | 0.4 | $4.5M | 2.0M | 2.31 | |
| Pernix Therapeutics Hldgs In dbcv 4.250% 4/0 | 0.4 | $4.3M | 16M | 0.28 | |
| Nexvet Biopharma Pub Ltd Co ord | 0.4 | $4.2M | 1.0M | 4.15 | |
| Mediwound Ltd cmn | 0.4 | $4.1M | 531k | 7.70 | |
| Anthera Pharmaceutcls | 0.3 | $3.6M | 1.2M | 3.15 | |
| Contrafect | 0.3 | $3.5M | 1.4M | 2.48 | |
| Trevena | 0.3 | $3.3M | 492k | 6.75 | |
| Trupanion (TRUP) | 0.2 | $2.7M | 159k | 16.90 | |
| Tandem Diabetes Care | 0.2 | $2.6M | 334k | 7.66 | |
| Windtree Therapeutics | 0.2 | $2.0M | 778k | 2.56 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 | 0.2 | $1.9M | 167k | 11.45 | |
| Dextera Surgical | 0.1 | $1.6M | 844k | 1.88 | |
| CAS Medical Systems | 0.1 | $972k | 562k | 1.73 | |
| Strata Skin Sciences Incorporated | 0.1 | $510k | 961k | 0.53 | |
| Rxi Pharmaceuticals Corp | 0.1 | $585k | 316k | 1.85 |
